改变MAPK通路的H3K27扩散中线质瘤:预后和治疗影响
Catherine Gestrich1, Kristina Grieco2, Hart G Lidov1
1Department of Pathology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
Journal of neuropathology and experimental neurology
|December 1, 2023
概括
分析了像FGFR1和BRAF在H3K27突变扩散中线质瘤 (DMGs) 中的遗传变化. 对于潜在的向疗法,建议对这些H3K27改变的质瘤进行全面测序.
科学领域:
- 神经瘤学神经瘤学
- 分子病理学分子病理学
- 基因组学就是基因组学.
背景情况:
- 有H3K27突变的扩散中线质瘤 (DMG) 是一种罕见但具有攻击性的脑瘤.
- 在一些DMG中发现了包括FGFR1和BRAF在内的驱动分子变异,但它们的临床意义需要进一步探索.
研究的目的:
- 研究H3K27突变质瘤中基因变异 (FGFR1,BRAF,KRAS,NRAS) 的同时发生和临床意义.
- 评估这些变化对机构队列患者结果的影响.
主要方法:
- 对H3K27突变质瘤机构档案的回顾性分析.
- 综合基因变异分析,包括突变分析.
- 人口,临床和病理学数据的审查.
- 使用R包 maftools生成Oncoplot和卡普兰-梅尔生存曲线.
主要成果:
- 81名患有H3K27突变质瘤的患者被确定;79人是DMG.
- 突变的发生率:BRAF V600E (4),FGFR1热点 (12),KRAS (1),NRAS (1).这些突变的发生率为:
- BRAF突变与大脑干位置相关;FGFR1突变与thalamic位置相关.
- 与野生型相比,FGFR1-或BRAF V600E突变DMG的总生存率没有统计学上显著的改善.
结论:
- 虽然FGFR1和BRAF突变并没有提高这一队列的生存率,但它们在H3K27改变的质瘤中的存在需要进一步调查.
- 对H3K27突变质瘤进行全面的基因组分析对于识别针对性治疗的潜在候选人至关重要.
更多相关视频
06:32Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
Published on: January 9, 2019
7.9K
09:17Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma
Published on: September 13, 2022
2.3K
相关概念视频
MAPK Signaling Cascades
5.6K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.6K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Microtubule Associated Proteins (MAPs)
4.3K
Microtubule function and architecture are regulated by an array of specialized proteins called microtubule-associated proteins or MAPs. These proteins are widespread across different organisms and have conserved protein motifs, like the multi-TOG domain for tubulin binding found in the CLASP family of MAPs. Some MAPs are lineage-specific based on their conserved domains. Their functions depend upon the cytoskeletal architecture and cell type they are located within. In-plant cells, a specific...
4.3K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
